(19) |
 |
|
(11) |
EP 2 204 185 A8 |
(12) |
CORRECTED EUROPEAN PATENT APPLICATION |
|
Note: Bibliography reflects the latest situation |
(15) |
Correction information: |
|
Corrected version no 1 (W1 A1) |
(48) |
Corrigendum issued on: |
|
27.10.2010 Bulletin 2010/43 |
(43) |
Date of publication: |
|
07.07.2010 Bulletin 2010/27 |
(22) |
Date of filing: 02.11.1995 |
|
(51) |
International Patent Classification (IPC):
|
|
(84) |
Designated Contracting States: |
|
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
(30) |
Priority: |
02.11.1994 GB 9422096
|
(62) |
Application number of the earlier application in accordance with Art. 76 EPC: |
|
03075069.9 / 1312377 |
|
95935550.4 / 0789587 |
(71) |
Applicant: Novartis Vaccines and Diagnostics S.r.l. |
|
53100 Siena (SI) (IT) |
|
(72) |
Inventors: |
|
- Ceccarini, Costante
53100 Siena (IT)
- D'Ascenzi, Sandro
53100 Siena (IT)
- Costantino, Paolo
53100 Siena (IT)
- Norelli, Francesco
53100 Siena (IT)
- Gianozzi, Aldo
53100 Siena (IT)
|
(74) |
Representative: Marshall, Cameron John et al |
|
Carpmaels & Ransford
One Southampton Row London
WC1B 5HA London
WC1B 5HA (GB) |
|
|
|
|
|
Remarks: |
|
This application was filed on 16-03-2010 as a divisional application to the application
mentioned under INID code 62. |
|
(54) |
Combined meningitis vaccine |
(57) A combined vaccine for bacterial meningitis comprises Hib and MenC saccharides.